Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP10162.RA4zt-gWDUwRFQ1ugc-Y1k_tJbLls65EoKtoxInCq6His130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP10162.RA4zt-gWDUwRFQ1ugc-Y1k_tJbLls65EoKtoxInCq6His130_assertion type Assertion NP10162.RA4zt-gWDUwRFQ1ugc-Y1k_tJbLls65EoKtoxInCq6His130_head.
- NP10162.RA4zt-gWDUwRFQ1ugc-Y1k_tJbLls65EoKtoxInCq6His130_assertion description "[The BRAFT1799A mutation confers sensitivity of thyroid cancer cells to the BRAFV600E inhibitor PLX4032 (RG7204).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP10162.RA4zt-gWDUwRFQ1ugc-Y1k_tJbLls65EoKtoxInCq6His130_provenance.
- NP10162.RA4zt-gWDUwRFQ1ugc-Y1k_tJbLls65EoKtoxInCq6His130_assertion evidence source_evidence_curated NP10162.RA4zt-gWDUwRFQ1ugc-Y1k_tJbLls65EoKtoxInCq6His130_provenance.
- NP10162.RA4zt-gWDUwRFQ1ugc-Y1k_tJbLls65EoKtoxInCq6His130_assertion SIO_000772 21185263 NP10162.RA4zt-gWDUwRFQ1ugc-Y1k_tJbLls65EoKtoxInCq6His130_provenance.
- NP10162.RA4zt-gWDUwRFQ1ugc-Y1k_tJbLls65EoKtoxInCq6His130_assertion wasDerivedFrom ctd_human-20130708 NP10162.RA4zt-gWDUwRFQ1ugc-Y1k_tJbLls65EoKtoxInCq6His130_provenance.
- NP10162.RA4zt-gWDUwRFQ1ugc-Y1k_tJbLls65EoKtoxInCq6His130_assertion wasGeneratedBy ECO_0000218 NP10162.RA4zt-gWDUwRFQ1ugc-Y1k_tJbLls65EoKtoxInCq6His130_provenance.